119 related articles for article (PubMed ID: 24318956)
21. Antiarrhythmic drug usage and prostate cancer: a population-based cohort study.
Kao LT; Huang CC; Lin HC; Huang CY
Asian J Androl; 2018; 20(1):37-42. PubMed ID: 28857052
[TBL] [Abstract][Full Text] [Related]
22. Inflammatory Bowel Disease and the Risk of Prostate Cancer.
Burns JA; Weiner AB; Catalona WJ; Li EV; Schaeffer EM; Hanauer SB; Strong S; Burns J; Hussain MHA; Kundu SD
Eur Urol; 2019 May; 75(5):846-852. PubMed ID: 30528221
[TBL] [Abstract][Full Text] [Related]
23. Statin use and risk of prostate cancer: a Danish population-based case-control study, 1997-2010.
Jespersen CG; Nørgaard M; Friis S; Skriver C; Borre M
Cancer Epidemiol; 2014 Feb; 38(1):42-7. PubMed ID: 24275259
[TBL] [Abstract][Full Text] [Related]
24. Statin use in relation to prostate cancer outcomes in a population-based patient cohort study.
Geybels MS; Wright JL; Holt SK; Kolb S; Feng Z; Stanford JL
Prostate; 2013 Aug; 73(11):1214-22. PubMed ID: 23633265
[TBL] [Abstract][Full Text] [Related]
25. Occupation, industry, and the risk of prostate cancer: a case-control study in Montréal, Canada.
Sauvé JF; Lavoué J; Parent MÉ
Environ Health; 2016 Oct; 15(1):100. PubMed ID: 27769264
[TBL] [Abstract][Full Text] [Related]
26. Associations of tea and coffee consumption with prostate cancer risk.
Geybels MS; Neuhouser ML; Stanford JL
Cancer Causes Control; 2013 May; 24(5):941-8. PubMed ID: 23412806
[TBL] [Abstract][Full Text] [Related]
27. Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.
Yli-Hemminki TH; Laurila M; Auvinen A; Määttänen L; Huhtala H; Tammela TL; Kujala PM
BJU Int; 2013 Oct; 112(6):735-41. PubMed ID: 23746332
[TBL] [Abstract][Full Text] [Related]
28. Prostate cancer mortality in relation to screening by prostate-specific antigen testing and digital rectal examination: a population-based study in middle-aged men.
Agalliu I; Weiss NS; Lin DW; Stanford JL
Cancer Causes Control; 2007 Nov; 18(9):931-7. PubMed ID: 17641982
[TBL] [Abstract][Full Text] [Related]
29. Usual adult occupation and risk of prostate cancer in West African men: the Ghana Prostate Study.
Adler C; Friesen MC; Yeboah ED; Tettey Y; Biritwum RB; Adjei AA; Tay E; Okyne V; Mensah JE; Truelove A; Yang B; Kelly SP; Zhou CK; McCullough LE; Pardo L; Hoover RN; Hsing AW; Cook MB; Koutros S
Occup Environ Med; 2019 Feb; 76(2):71-77. PubMed ID: 30530485
[TBL] [Abstract][Full Text] [Related]
30. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
31. Risk of digoxin intoxication in heart failure patients exposed to digoxin-diuretic interactions: a population-based study.
Wang MT; Su CY; Chan AL; Lian PW; Leu HB; Hsu YJ
Br J Clin Pharmacol; 2010 Aug; 70(2):258-67. PubMed ID: 20653679
[TBL] [Abstract][Full Text] [Related]
32. Sexually transmitted diseases and other urogenital conditions as risk factors for prostate cancer: a case--control study in Wayne County, Michigan.
Patel DA; Bock CH; Schwartz K; Wenzlaff AS; Demers RY; Severson RK
Cancer Causes Control; 2005 Apr; 16(3):263-73. PubMed ID: 15947878
[TBL] [Abstract][Full Text] [Related]
33. General and abdominal obesity trajectories across adulthood, and risk of prostate cancer: results from the PROtEuS study, Montreal, Canada.
Vallières E; Mésidor M; Roy-Gagnon MH; Richard H; Parent MÉ
Cancer Causes Control; 2021 Jun; 32(6):653-665. PubMed ID: 33818663
[TBL] [Abstract][Full Text] [Related]
34. Circumcision and the risk of prostate cancer.
Wright JL; Lin DW; Stanford JL
Cancer; 2012 Sep; 118(18):4437-43. PubMed ID: 22411189
[TBL] [Abstract][Full Text] [Related]
35. Association between dietary flavonoids intake and prostate cancer risk: A case-control study in Sicily.
Reale G; Russo GI; Di Mauro M; Regis F; Campisi D; Giudice AL; Marranzano M; Ragusa R; Castelli T; Cimino S; Morgia G
Complement Ther Med; 2018 Aug; 39():14-18. PubMed ID: 30012385
[TBL] [Abstract][Full Text] [Related]
36. Vitamin and mineral supplement use is associated with reduced risk of prostate cancer.
Kristal AR; Stanford JL; Cohen JH; Wicklund K; Patterson RE
Cancer Epidemiol Biomarkers Prev; 1999 Oct; 8(10):887-92. PubMed ID: 10548317
[TBL] [Abstract][Full Text] [Related]
37. Aspirin and NSAID use in association with molecular subtypes of prostate cancer defined by TMPRSS2:ERG fusion status.
Wright JL; Chéry L; Holt S; Lin DW; Luedeke M; Rinckleb AE; Maier C; Stanford JL
Prostate Cancer Prostatic Dis; 2016 Mar; 19(1):53-6. PubMed ID: 26503111
[TBL] [Abstract][Full Text] [Related]
38. Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era.
Chen YC; Page JH; Chen R; Giovannucci E
Prostate; 2008 Oct; 68(14):1582-91. PubMed ID: 18646000
[TBL] [Abstract][Full Text] [Related]
39. Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer.
Preston MA; Batista JL; Wilson KM; Carlsson SV; Gerke T; Sjoberg DD; Dahl DM; Sesso HD; Feldman AS; Gann PH; Kibel AS; Vickers AJ; Mucci LA
J Clin Oncol; 2016 Aug; 34(23):2705-11. PubMed ID: 27298404
[TBL] [Abstract][Full Text] [Related]
40. Waist circumference, waist-hip ratio, body mass index, and prostate cancer risk: results from the North-American case-control study Prostate Cancer & Environment Study.
Boehm K; Sun M; Larcher A; Blanc-Lapierre A; Schiffmann J; Graefen M; Sosa J; Saad F; Parent MÉ; Karakiewicz PI
Urol Oncol; 2015 Nov; 33(11):494.e1-7. PubMed ID: 26278366
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
